Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 225.71M P/E - EPS this Y -15.50% Ern Qtrly Grth -
Income -43.53M Forward P/E -4.89 EPS next Y 4.60% 50D Avg Chg -
Sales 4.79M PEG - EPS past 5Y - 200D Avg Chg 19.00%
Dividend N/A Price/Book 1.78 EPS next 5Y - 52W High Chg -26.00%
Recommedations 1.50 Quick Ratio 5.08 Shares Outstanding 34.37M 52W Low Chg 81.00%
Insider Own 42.58% ROA -20.36% Shares Float 13.20M Beta 0.60
Inst Own 28.45% ROE -36.94% Shares Shorted/Prior 53.70K/48.03K Price 7.88
Gross Margin 62.50% Profit Margin - Avg. Volume 10,543 Target Price 17.00
Oper. Margin -1,725.94% Earnings Date Nov 6 Volume 1,030 Change -4.66%
About Nyxoah SA

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Nyxoah SA News
12/20/24 Publication relating to transparency notifications
12/16/24 Nyxoah introduces neurostimulator device for sleep apnoea in England
12/13/24 Tongue Implant Could Treat Sleep Apnea Without a CPAP
12/13/24 Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England
11/27/24 Information on the total number of voting rights and shares
11/20/24 Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference
11/19/24 Invitation to attend the special shareholders’ meeting of the Company to be held on December 19, 2024
11/07/24 Nyxoah SA (NYXH) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
11/06/24 Nyxoah SA (NYXH) Reports Q3 Loss, Tops Revenue Estimates
11/06/24 Nyxoah Reports Third Quarter Financial and Operating Results
11/04/24 Nyxoah Appoints John Landry as Chief Financial Officer
10/31/24 Privia Health (PRVA) Earnings Expected to Grow: Should You Buy?
10/30/24 Nyxoah SA (NYXH) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
10/22/24 Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024
10/09/24 Nyxoah SA (NYXH) Q2 2024 Earnings Call Highlights: Strategic Growth and US Market Preparations
10/08/24 Nyxoah Secures $27 Million to Boost U.S. Presence
10/07/24 Nyxoah Raises $27 Million through its At-the-Market Offering
09/27/24 DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update
09/05/24 Nyxoah to Participate in Upcoming Investor Conferences
09/02/24 Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device
NYXH Chatroom

User Image PaulLaurent Posted - 1 week ago

Watchlist online! check my bio for more! $TRUG - trending on social media $GRRR - SC-13 filing $TNXP - possible multi day runner $NYXH - Commercial Launch of Genio® Innovative Therapy in England As always, have a perfect day!

User Image PenkeTrading Posted - 1 month ago

I found you an Oversold RSI (Relative Strength Index) on the daily chart of Nyxoah. Is that bullish or bearish? $NYXH #Nyxoah #RsiOversold #NASDAQ

User Image Torontinoo_Banana_Genius Posted - 1 month ago

$NYXH new med tech company with minimally invasive surgical alternative to CPAP for OSA. Some competition for $INSP. 🤔. Starter in NYXH to monitor.

User Image Thestocktraderhubzee Posted - 1 month ago

WATCHLIST NOV 06 2024.. $NYXH Cantor Fitzgerald Reiterates Overweight on Nyxoah, Maintains $16 Price Target $EVEX Cantor Fitzgerald Reiterates Overweight on Eve Holding, Maintains $5 Price Target $CTOS Oppenheimer Maintains Outperform on Custom Truck One Source, Lowers Price Target to $5 $EDIT RBC Capital Maintains Sector Perform on Editas Medicine, Lowers Price Target to $5 $ALL Wells Fargo Maintains Equal-Weight on Allstate, Raises Price Target to $186

User Image LoyalShark Posted - 1 month ago

$NSPR Just seeing $NYXH has its price target raised to $16 by Cantor Fiitzgerald. They make Sleep Apnea with a platform called Genio that is CE- mark validated. Revs are $4.79 million expected '24 Mrkt Cap $305.81 Million. Losing money every day. Compare it to NSPR. Let me know what your thoughts on as to why $NYXH would have a higher valuation than NSPR. Compare their numbers - ratios. Maddening NSPR would be SUCKING air due to an incompaetent CEO's approach to creting a following. WHY would $NYXH have 7 analysts following and $NSPR have ONE ...that was paid to be there. Why would they get a MUCH higher valuation based on sales, cash flow, ebitda etc. Its the difference of a PUBLIC MARKET know how. Public Market IQ. When you suck at it -- you suck at it. NSPR's CEO sucks at it.

User Image themacromindset Posted - 2 months ago

$NYXH Nyxoah Raises $27 Million through its At-the-Market Offering

User Image DonCorleone77 Posted - 2 months ago

$NYXH Nyxoah raises $27M through at-the-market offering Nyxoah SA "announced that the Company has sold 3.0 million shares raising $27.0 million in gross proceeds pursuant to the Company's $50 million at-the-market offering at a price per share equal to the market price on the Nasdaq Global Market at the time of sale. The shares were sold, based on interest received, to a single U.S.-based healthcare investor. Cantor Fitzgerald & Co. is acting as the sales agent for the ATM offering."

User Image _www_larval_com_ Posted - 2 months ago

$NYXH has reversed 4% higher to 0% (~3Mv) moments ago, follow for more volatility.

User Image DogStarGlobal Posted - 09/29/24

$NYXH Nyxoah

User Image jParkz Posted - 09/27/24

$NYXH News DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update https://marketwirenews.com/news-releases/dream-pivotal-study-data-presented-at-the-internatio-4728957683132987.html $NYXH

User Image Stock_Titan Posted - 09/27/24

$NYXH Publication relating to transparency notifications https://www.stocktitan.net/news/NYXH/publication-relating-to-transparency-cboi0es5giof.html

User Image Stock_Titan Posted - 3 months ago

$NYXH Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device https://www.stocktitan.net/news/NYXH/nyxoah-rings-the-closing-bell-at-nasdaq-while-preparing-for-u-s-8pqc1dtrmaof.html

User Image Thestocktraderhubzee Posted - 4 months ago

$NYXH HC Wainwright & Co. Reiterates Buy on Nyxoah, Maintains $18 Price Target

User Image Stock_Titan Posted - 4 months ago

$NYXH Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating Results https://www.stocktitan.net/news/NYXH/nyxoah-reports-second-quarter-and-first-half-2024-financial-and-k7wzvh1d24ke.html

User Image Stock_Titan Posted - 07/29/24

$NYXH Nyxoah to Release Second Quarter and First Half 2024 Financial Results on August 6, 2024 https://www.stocktitan.net/news/NYXH/nyxoah-to-release-second-quarter-and-first-half-2024-financial-e2fcvli4xt0k.html

User Image chaostrader Posted - 5 months ago

$NYXH Part of the loan agreement, Nyxoah will grant the EIB 468,384 synthetic warrants with a strike price of €8.11. These warrants are exercisable after five years or in exceptional situations, allowing the EIB to receive cash based on Nyxoah's stock performance​. https://www.pharmiweb.com/press-release/2024-07-03/nyxoah-has-signed-a-375-million-loan-facility-agreement-with-the-european-investment-bank

User Image Moondusterke2 Posted - 5 months ago

$NYXH **

User Image OpenOutcrier Posted - 5 months ago

$NYXH (+2.1% pre) Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank https://ooc.bz/l/36861

User Image Stock_Titan Posted - 5 months ago

$NYXH Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank https://www.stocktitan.net/news/NYXH/nyxoah-has-signed-a-eu37-5-million-loan-facility-agreement-with-the-zy8nmuhtx7uk.html

User Image Stock_Titan Posted - 5 months ago

$NYXH Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA https://www.stocktitan.net/news/NYXH/nyxoah-submits-fourth-and-final-module-in-pma-application-for-genio-s97mfyfzhrnu.html

User Image AnaChart Posted - 06/24/24

$NYXH https://anachart.com/wp-content/uploads/ana_temp/1719234125_soc-img.jpg

User Image DonCorleone77 Posted - 06/24/24

$INSP $NYXH $LLY Inspire Medical price target lowered to $170 from $210 at Stifel Stifel analyst Jonathan Block lowered the firm's price target on Inspire Medical (INSP) to $170 from $210 and keeps a Hold rating on the shares. Additional data from Eli Lilly's (LLY) SURMOUNT-OSA trial that was released late Friday afternoon raises more questions for Inspire Medical and the HGNS market than it offers answers, the analyst tells investors. The incremental information, notably the percent of obstructive sleep apnea, or OSA, patients no longer considered moderate or severe at week 52, makes the firm "more concerned on out-year numbers," and it lowered estimates and targets for both Inspire and Nyxoah (NYXH), the analyst added.

User Image Americanbulls Posted - 6 months ago

$NYXH apparently the bear pattern is not confirmed. Prices continue to rise. www.Americanbulls.com/SignalPage.aspx?lang=en&Ticker=NYXH

User Image Stock_Titan Posted - 6 months ago

$NYXH Publication relating to transparency notifications https://www.stocktitan.net/news/NYXH/publication-relating-to-transparency-peo6f27ubcdn.html

User Image TheDizPlinTrader Posted - 05/25/24

$NYXH slightly below where it should be, but a green finish is promising! I will come back and asses the situation with new levels soon. Have a lovely weekend! David.

User Image Celz Posted - 05/24/24

$NYXH

User Image TheDizPlinTrader Posted - 05/24/24

$NYXH Daily Analysis: 1-Hour Support & Resistance Zones 🚀 Current Price: $8.64 🔹 Support Levels: Immediate support at $8.65 (Just broke) Stronger support at $8.50 🔸 Resistance Levels: Immediate resistance at $8.90 Longer-term resistance at $9.05 📊 Watch these key levels for potential trading opportunities! Stay disciplined! ⚔️

User Image DonCorleone77 Posted - 7 months ago

$NYXH Nyxoah 5.374M share Spot Secondary priced at $9.25 Cantor Fitzgerald acted as lead book running manager for the offering.

User Image Stock_Titan Posted - 7 months ago

$NYXH Nyxoah Announces Pricing of Offering https://www.stocktitan.net/news/NYXH/nyxoah-announces-pricing-of-ybisb9v9zp4a.html

User Image OpenOutcrier Posted - 7 months ago

$NYXH (-9.1% pre) Nyxoah Announces Proposed Offering of Ordinary Shares - GN https://ooc.bz/l/33802

Analyst Ratings
HC Wainwright & Co. Buy Sep 30, 24
Cantor Fitzgerald Overweight Aug 7, 24
HC Wainwright & Co. Buy Aug 7, 24
Oppenheimer Outperform Aug 7, 24
Stifel Buy Jun 24, 24
HC Wainwright & Co. Buy May 24, 24
HC Wainwright & Co. Buy May 15, 24
Oppenheimer Outperform May 15, 24
Cantor Fitzgerald Overweight May 15, 24